Why do neuropsychiatric trials fail? Experts Dr. Steve Brannan and Dr. David Walling share strategies to protect investments in neuropsychiatric drug development.
Experienced CRO executive joins Cognitive Research Corporation to expand partnerships and strengthen its position as a leading CRO for CNS clinical trials
Psychedelic clinical research is advancing. Explore how trials with psilocybin, LSD, MDMA, and DMT are redefining protocols, standards, and future therapies.